ATXI

AVENUE THERAPEUTICS, INC.

OTC · Pharmaceutical Preparations · Inc. DE · CIK 0001644963
$0.3600 +16.13%
Vol
Inst. Holders2 funds
Inst. Value$16.8K
Inst. Activity0 buys / 1 sells
Exchange OTC·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001644963·Prev Close $0.3100

Recent Activity

Inst.
UBS Group AG — EXIT
0 shares ($0.00)
Inst.
UBS Group AG — ADD
7,920 shares ($15.8K)
May 13, 2026 earnings_calendar
ATXI Q1 2026 Earnings Scheduled — 2026-05-13

Analyst Ratings

Historical distribution86% buy · 7 analysts · last covering-analyst action Dec 2023
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Dec 11, 2023 Maxim Group INITIATE Buy
Apr 3, 2023 Aegis Capital INITIATE Buy

Top Institutional Holders

FundValueMove
UBS Group AG$15.8KEXIT
WELLS FARGO & COMPANY/MN$1.0K
2 institutional holders with $16.8K total value (8,420 shares) as of 2024-Q4. Top holders: UBS, WELLS. Net buying activity: 1 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2024-Q4

#FundSharesValue% of TrackedLast Move
1UBS Group AG7,920$15.8K94.1%EXIT -100.0%
2WELLS FARGO & COMPANY/MN500$1.0K5.9%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
UBS Group AGEXIT7,9200-100.0%$0.002025-Q1
UBS Group AGADD6,1437,920+28.9%$15.8K2024-Q4

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Dec 2023): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2024-12-31
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2024-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 2 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Dec 11, 2023 Maxim Group INITIATE Buy
Apr 3, 2023 Aegis Capital INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
May 1, 20252410086%
Apr 1, 20252410086%
Mar 1, 20252410086%
Feb 1, 20252410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 13, 2026
earnings_calendar
ATXI Q1 2026 Earnings Scheduled — 2026-05-13
Mar 30, 2026
earnings_calendar
ATXI Q4 2025 Earnings After Market Close — 2026-03-30